ISRN Oncology · 2013 · 22 citations · 14 references
MedicineOncologyChemotherapyOral OncologySurgical OncologyCancer StagingOropharyngeal CancerTherapy Response AssessmentPost-treatment Response AssessmentRecist CriteriaTherapy Response EvaluationTreatment Response CriteriaTumor Response EvaluationTumor Response Prediction
This study studied the coorelation between radiological response to induction chemotherapy and acheivement of pCR or near pCR. It was a retrospective analysis in which all patients who received NACT from 2008 till april 2012 were subjected to inclusion criteria. Coorelation analysis was performed between CR + PR and acheivement of pCR or near pCR. Twenty four patients were identified.The primary site of tumor was oral cavity in 19 patients (79.2%), maxilla in 2 patients (4.2%), laryngopharynx in 2 patients (4.2%) and oropharynx in 1 patient (4.2%). The clinical stage was stage IVA in 16 patients ( 66.7%) and IVB in 8 patients (33.3%). The overall response rates ie a combination of CR and PR was seen in 11patients (45.8%). The pCR was seen in 15 patients (62.5%) and rest had near pCR. There was no linear coorelation between radiological size decrement and tumor response. On coorelation analysis the spearman correlation coefficent was -0.039 (P = 0.857). This suggest that presently used radiological response criterias for response assesment in head and neck cancers severly limit our ability to identify patients who would have pCR or near pCR.
14
Jacob Cohen · Psychological Bulletin · 1992 · 42.2K citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Medicine, Oncology, Chemotherapy +8